# Microbial Study of Sublingual Immunotherapy Tablets in Patients With Allergic Rhinitis

> **NCT06741800** · — · NOT_YET_RECRUITING · sponsor: **The First Affiliated Hospital with Nanjing Medical University** · enrollment: 100 (estimated)

## Conditions studied

- Rhinitis, Allergic

## Interventions

- **DRUG:** ACARIZAX®️

## Key facts

- **NCT ID:** NCT06741800
- **Lead sponsor:** The First Affiliated Hospital with Nanjing Medical University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-12-20
- **Primary completion:** 2028-07
- **Final completion:** 2032-07
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2024-12-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06741800

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06741800, "Microbial Study of Sublingual Immunotherapy Tablets in Patients With Allergic Rhinitis". Retrieved via AI Analytics 2026-09-04 from https://api.ai-analytics.org/clinical/NCT06741800. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*